Mass Spectrometry Market Poised for .52 Billion Growth from 2024 - 2028

The mass spectrometry market is projected to expand by $3.52 billion between 2024 and 2028, growing at a CAGR of 12.26%. This growth is driven by increasing demand in pharmaceutical and biotechnology industries, advancements in hyphenated technologies, and the rising focus on drug discovery and development. The expanding geriatric population and demand for precision healthcare solutions are also fueling adoption.

For more details about the industry, get the PDF sample report for free

Market Segmentation

By End-User:

• Pharmaceutical and biotechnology industries (largest segment)
• Chemical and petrochemical industries
• Others

By Product:

• Instruments
• Consumables and services

By Geography:

• North America
  • Canada
  • US
• Europe
  • Germany
  • UK
• Asia
  • China
• Rest of World (ROW)

Key Market Dynamics

Drivers:

• Increase in use of hyphenated technology
  • Liquid Chromatography-Mass Spectrometry (LC-MS) is widely used for drug discovery, environmental testing, and personalized medicine.
  • Growing investment in biopharmaceuticals, drug safety, and late-stage development is fueling demand.

Trends:

• Rising demand for mass spectrometers in personalized medicine
  • The need for high-precision drug analysis in clinical trials and biopharmaceutical R&D is accelerating adoption.
  • AI-powered MS systems are gaining traction for faster and more accurate diagnostic insights.

Challenges:

• High cost of mass spectrometry instruments
  • The expensive equipment and maintenance costs are limiting adoption, especially in emerging markets.
  • Customization for specific applications further increases operational expenses.

Get more details by ordering the complete report

Key Players

• 908 Devices Inc.
• ABB Ltd.
• Agilent Technologies Inc.
• Bruker Corp.
• Endress Hauser Group Services AG
• European Virtual Institute for Speciation Analysis
• JEOL Ltd.
• Kore Technology Ltd.
• LECO Corp.
• PerkinElmer Inc.
• Rigaku Corp.
• Shimadzu Corp.
• Teledyne Technologies Inc.
• Thermo Fisher Scientific Inc.
• Waters Corp.

Latest Market Developments

• January 2025 – Thermo Fisher Scientific launched a high-resolution mass spectrometer optimized for proteomics research and drug discovery.
• December 2024 – Agilent Technologies introduced a mass spectrometry system for environmental and food safety testing, capable of detecting trace contaminants.
• November 2024 – Waters Corporation unveiled an AI-driven mass spectrometer for real-time clinical diagnostics, enhancing metabolic disease detection.
• October 2024 – SCIEX released a mass spectrometry platform for pharmaceutical applications, improving drug metabolite detection and clinical trial efficiency.